Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Vaso-Occlusive Pain Episode in Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Bordeaux, Bordeaux, France
Contact: Study coordinator (Arthur ORIEUX) · arthur.orieux@chu-bordeaux.fr · 05.56.79.56.79
CHU Lille, Lille, France
Contact: Study coordinator (Arthur DURAND) · arthur.durand@chu-lille.fr · 03.20.44.40.84
CHU La Timone, Marseille, France
Contact: Study coordinator (Jérémy BOURENNE) · jeremy.bourenne@ap-hm.fr · 04.13.42.95.96
CHU de Nantes, Nantes, France
Contact: Study coordinator (Maïté AGBAKOU) · maite.agbakou@chu-nantes.fr · 02.40.76.80.54
CHU Orléans, Orléans, France
Contact: Study coordinator (Marie SKARZYNSKI) · Marie.skarzynski@chu-orleans.fr · 02.38.51.44.46
Hôpital Tenon APHP, Paris, France
Contact: Study coordinator (Muriel FARTOUKH) · muriel.fartoukh@aphp.fr · 01.56.01.61.32
CHU Poitiers, Poitiers, France
Contact: Study coordinator (Delphine CHATELLIER) · delphine.chatellier@chu-poitiers.fr · 05.49.44.43.67
CHU Rouen, Rouen, France
Contact: Study coordinator (Maximilien GRALL) · maximilien.grall@chu-rouen.fr · 02.32.88.58.28
Oncopole Toulouse, Toulouse, France
Contact: Study coordinator (Sihem BOUHARAOUA) · Bouharaoua.sihem@iuct-oncopole.fr · 05.31.15.61.14
CHRU Tours - Hôpital Bretonneau, Tours, France
Contact: Study coordinator (Charlotte SALMONGANDONNIERE) · c.salmon-gandonniere@chu-tours.fr · 02.47.47.38.55
CHU Guadeloupe, Les Abymes, Guadeloupe
Contact: Study coordinator (Frédéric MARTINO) · frederic.martino@chu-guadeloupe.fr · 05.90.89.11.32

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Sickle Cell Disease · Vaso-occlusive Pain Episode

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Sickle Cell Disease · Vaso-Occlusive Pain Episode in Sickle Cell Disease · Ketamine Infusion

Abroad (travel likely)RecruitingPHASE2

Torrance, United States

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Sickle Cell Disease (SCD) · Vaso-Occlusive Pain Episode in Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE4

Atlanta, United States · Philadelphia, United States

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Sickle Cell Disease · Vaso-occlusive Pain Episode in Sickle Cell Disease · Acute Pain

Abroad (travel likely)Recruiting

Baltimore, United States